Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis

Detalles Bibliográficos
Autores principales: Guglielmelli, P, Rotunno, G, Fanelli, T, Pacilli, A, Brogi, G, Calabresi, L, Pancrazzi, A, Vannucchi, A M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635198/
https://www.ncbi.nlm.nih.gov/pubmed/26473532
http://dx.doi.org/10.1038/bcj.2015.90
_version_ 1782399475974668288
author Guglielmelli, P
Rotunno, G
Fanelli, T
Pacilli, A
Brogi, G
Calabresi, L
Pancrazzi, A
Vannucchi, A M
author_facet Guglielmelli, P
Rotunno, G
Fanelli, T
Pacilli, A
Brogi, G
Calabresi, L
Pancrazzi, A
Vannucchi, A M
author_sort Guglielmelli, P
collection PubMed
description
format Online
Article
Text
id pubmed-4635198
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46351982015-11-25 Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis Guglielmelli, P Rotunno, G Fanelli, T Pacilli, A Brogi, G Calabresi, L Pancrazzi, A Vannucchi, A M Blood Cancer J Letter to the Editor Nature Publishing Group 2015-10 2015-10-16 /pmc/articles/PMC4635198/ /pubmed/26473532 http://dx.doi.org/10.1038/bcj.2015.90 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Guglielmelli, P
Rotunno, G
Fanelli, T
Pacilli, A
Brogi, G
Calabresi, L
Pancrazzi, A
Vannucchi, A M
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title_full Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title_fullStr Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title_full_unstemmed Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title_short Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
title_sort validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like calr mutations in myelofibrosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635198/
https://www.ncbi.nlm.nih.gov/pubmed/26473532
http://dx.doi.org/10.1038/bcj.2015.90
work_keys_str_mv AT guglielmellip validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT rotunnog validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT fanellit validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT pacillia validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT brogig validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT calabresil validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT pancrazzia validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis
AT vannucchiam validationofthedifferentialprognosticimpactoftype1type1likeversustype2type2likecalrmutationsinmyelofibrosis

Ejemplares similares